MedPath

The Multicenter Randomized HYpertension and VALUEs (HYVALUE) Trial

Not Applicable
Completed
Conditions
Hypertension
Interventions
Behavioral: Intervention Values Affirmation
Behavioral: Control Values Affirmation
Registration Number
NCT03028597
Lead Sponsor
University of Colorado, Denver
Brief Summary

The objective of this study is to reduce the effects of stereotype threat on the adherence of African American patients with hypertension.

The specific aims of this study, which employs a values affirmation intervention, are to:

1. Compare the effects of the values-affirmation exercise to a control condition on antihypertensive medication adherence in African American patients with uncontrolled hypertension across three clinical settings,

2. Compare the effects of the values-affirmation exercise on antihypertensive medication adherence in African American patients and white patients with uncontrolled hypertension and similar socioeconomic characteristics, and

3. Evaluate the intervention for widespread dissemination using the RE-AIM (reach, effectiveness, adoption, implementation and maintenance) framework

Detailed Description

One in 3 US adults has hypertension and African Americans are disproportionately affected; almost 40% of non-Hispanic blacks have hypertension. Although the rates of uncontrolled hypertension have been decreasing in all groups, African Americans continue to have higher rates of uncontrolled hypertension compared to white Americans. The Institute of Medicine, World Health Organization and others have identified poor adherence to medications as the most significant, modifiable contributor to uncontrolled hypertension.

Stereotype threat may contribute to low adherence. Stereotype threat occurs when cues in the environment (such as visiting a doctor's office) trigger the threat of confirming, as self-characteristic, a negative stereotype about one's group. Although any individual may experience stereotype threat, African Americans are at greater risk due to widespread racism and past experiences of discrimination.

Values affirmation interventions reduce stereotype threat and decrease racial disparities in various outcomes. Values affirmation exercises typically ask participants to write a few sentences about their core values. By focusing on values that are important to them, values affirmation bolsters a person's self-concept by helping them view themselves as adequate, effective, and able to control important outcomes in spite of a possible threat.

Based on the evidence supporting the effectiveness of values affirmation in educational and other settings, the investigators hypothesize that values affirmation can similarly reduce racial disparities in medication adherence and subsequent health outcomes. By asking participating intervention patients to engage in a values affirmation exercise at an initial appointment with a primary care provider, the investigators hope to improve hypertensive medication adherence, systolic blood pressure, time under blood pressure control, and treatment intensification, and to reduce racial disparities in these outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
960
Inclusion Criteria
  • Hypertension diagnosis: primary or secondary ICD-10 code diagnosis in last 24 mo
  • SBP >140 mm Hg or DBP >90 mm Hg in last 12 months
  • Currently taking antihypertensive medications
  • Medications filled within health system's pharmacy
  • White or African American, self-reported race
  • Upcoming primary care visit
  • Ability to read and write English
Exclusion Criteria
  • Pregnancy-related hypertension
  • Dialysis-dependent end-stage renal disease
  • Prisoners
  • Unable to provide consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Values AffirmationIntervention Values AffirmationThe task first asks patients to reflect on a list of 11 personal values or self-defining skills.
Control Values AffirmationControl Values AffirmationThe task first asks patients to reflect on a list of 11 personal values or self-defining skills.
Primary Outcome Measures
NameTimeMethod
Change in Antihypertensive Medication Adherence using Pharmacy RecordsBaseline, 3 and 6 months

This antihypertensive medication adherence outcome will be a summary measure of adherence which assesses the proportion of days covered (PDC) over the period of observation for which a patient obtains antihypertensive medications. Adherence will be calculated for each antihypertensive drug in the regimen and combined across drugs into a summary measure of adherence for the entire drug regimen.

Change in Antihypertensive Medication Adherence using Self-Reported AdherenceBaseline, 3 and 6 months

This antihypertensive medication adherence outcome will be a summary measure of self-reported adherence using the validated Voils instrument, which has 3 questions that address adherence over the previous 7 days.

Change in Antihypertensive Medication Adherence using Pill CountsBaseline, 3 and 6 months

This antihypertensive medication adherence outcome will be a summary outcome measure of adherence where if x is the number of pills in the bottle, y is the number of pills that would have been in the bottle had all pills been taken since the bottle was filled, and z is the number of pills that should have been taken since the last fill, and adherence is calculated as 1- \[(x-y)/z\].

Secondary Outcome Measures
NameTimeMethod
Proportion of Time Blood Pressure is Under Control6 months

Defined as the proportion of time over the 6-months of follow-up with a BP ≤ 140/90 mmHg.

Average Treatment Intensification6 months

Calculated by subtracting the number of expected intensifications (number of visits after enrollment with a BP ≥140/90 mm Hg) from the number of observed intensifications (either an increase in dose or addition of a new medication class), and then dividing this difference by the number of office visits over the observation period.

Systolic Blood PressureBaseline, 3 and 6 months

Systolic blood pressure over time

Trial Locations

Locations (3)

Kaiser Permanente Mid Atlantic States

🇺🇸

Rockville, Maryland, United States

Denver Health and Hospital Authority

🇺🇸

Denver, Colorado, United States

Kaiser Permanente of Colorado

🇺🇸

Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath